(1) Introduction: The ankle-brachial index (ABI) is the most widely used method of diagnosing peripheral arterial disease (PAD). However, the uptake of ABIs has been reported to be low in primary care settings across different various healthcare settings; however, this is yet to be investigated within the Canadian context. (2) Objective: Therefore, we sought to assess the rates of ABI usage as well as perceived barriers among primary care practitioners (PCPs) in Toronto, Canada. (3) Methods: A modified questionnaire was electronically sent to 257 PCPs in the Greater Toronto Area (GTA). Questions pertained to frequency, feasibility, utility, and barriers associated with ABI usage in clinical practice. Responses were collected and tallied. (4...
ObjectivesTo assess the prevalence and clinical significance of elevated ankle-brachial index (ABI) ...
Abstract. Background: Ankle brachial index (ABI) is a first line non-invasive screening tool for per...
Peripheral arterial disease (PAD) affects approximately 20% of patients aged ≥60 years.1 A GP with a...
(1) Introduction: The ankle-brachial index (ABI) is the most widely used method of diagnosing periph...
Background: Peripheral arterial disease (PAD) affects over 8 million people in the United States and...
Peripheral artery disease (PAD) is a strong predictor of cardiovascular morbidity and mortality yet ...
Peripheral arterial disease (PAD) is a marker of systemic atherosclerosis and associated with a thre...
Objectives: To determine the level of agreement between a 'conventional' Ankle-Brachial Index (ABI) ...
Background Peripheral Arterial Disease (PAD) is an increasingly prevalent long-term illness globall...
AbstractObjectivesDespite peripheral arterial disease (PAD), defined as ankle–brachial index (ABI)≤0...
Background: Peripheral arterial disease (PAD) can progress silently without any clinical symptoms. A...
Objective/Background: The Dutch College of General Practitioners' guideline on peripheral arterial d...
Peripheral arterial disease is a global health problem, affecting around 20% of people aged over 60 ...
ERMAInternational audienceBACKGROUND: Despite its validity as a screening test for peripheral arteri...
Peripheral artery disease (PAD), a common circulatory problem in which narrowed arteries reduce bloo...
ObjectivesTo assess the prevalence and clinical significance of elevated ankle-brachial index (ABI) ...
Abstract. Background: Ankle brachial index (ABI) is a first line non-invasive screening tool for per...
Peripheral arterial disease (PAD) affects approximately 20% of patients aged ≥60 years.1 A GP with a...
(1) Introduction: The ankle-brachial index (ABI) is the most widely used method of diagnosing periph...
Background: Peripheral arterial disease (PAD) affects over 8 million people in the United States and...
Peripheral artery disease (PAD) is a strong predictor of cardiovascular morbidity and mortality yet ...
Peripheral arterial disease (PAD) is a marker of systemic atherosclerosis and associated with a thre...
Objectives: To determine the level of agreement between a 'conventional' Ankle-Brachial Index (ABI) ...
Background Peripheral Arterial Disease (PAD) is an increasingly prevalent long-term illness globall...
AbstractObjectivesDespite peripheral arterial disease (PAD), defined as ankle–brachial index (ABI)≤0...
Background: Peripheral arterial disease (PAD) can progress silently without any clinical symptoms. A...
Objective/Background: The Dutch College of General Practitioners' guideline on peripheral arterial d...
Peripheral arterial disease is a global health problem, affecting around 20% of people aged over 60 ...
ERMAInternational audienceBACKGROUND: Despite its validity as a screening test for peripheral arteri...
Peripheral artery disease (PAD), a common circulatory problem in which narrowed arteries reduce bloo...
ObjectivesTo assess the prevalence and clinical significance of elevated ankle-brachial index (ABI) ...
Abstract. Background: Ankle brachial index (ABI) is a first line non-invasive screening tool for per...
Peripheral arterial disease (PAD) affects approximately 20% of patients aged ≥60 years.1 A GP with a...